Brainsway vs Pulsenmore
BWAY and PLSM side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BWAY and PLSM compare
Pulsenmore grew revenue faster over the last twelve months (314% versus 27.3% for Brainsway).
Brainsway scores higher on the StockData Score (5 against 3 for Pulsenmore), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BWAY | PLSM |
|---|---|---|
| Size and price | ||
| Share price | $10.25 | $1.38 |
| Change, 1 year | 35.0% | – |
| Change, 5 years | 158% | – |
| Beta (5Y) | 1.27 | – |
| Employees | 129 | 63 |
| StockData Score | ||
| Total score | 5 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 4 (better) | 2 |
| Performance score | 0 | 0 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | 27.3% | 314% (better) |
| Revenue growth, 5Y average | 18.8% | – |
| EPS growth (TTM) | 260% (better) | −57.3% |
| Profitability | ||
| Gross margin | 75.4% | 84.2% (better) |
| Operating margin | 8.3% | – |
| FCF margin | – | −82.5% |
| Financial health | ||
| Interest coverage | 2.0× | – |
| Current ratio | 3.59 (better) | 1.84 |
| Ownership | ||
| Held by institutions | 29.2% | 5.5% |
| Held by insiders | 25.5% | 31.8% |
| Insider net buying, 12 months | – | $15.7K |
| Superinvestors holding | – | 1 |
Go deeper
- BWAY stock overview
- BWAY income statement
- BWAY valuation and score
- PLSM stock overview
- PLSM income statement
- PLSM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.